Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Tria... by Tsuchiya-Kawano Y, Shiraishi Y, Kiyomi F, Okamoto I

Get full text

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye pat... by Miyake H, Kawano Y, Tanaka H, Iwata A, Imanaka T, Nakamura M

Get full text

Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status. by Isobe, N, Matsushita, T, Yamasaki, R, Ramagopalan, S, Kawano, Y, Nishimura, Y, Ebers, G, Kira, J

Epistatic interactions at HLA-DRB1 in Japanese patients with multiple sclerosis by Isobe, N, Matsushita, T, Yamasaki, R, Ramagopalan, S, Kawano, Y, Nishimura, Y, Ebers, G, Kira, J

The influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis with respect to the criteria of neuromyelitis optica by Isobe, N, Matsushita, T, Yamasaki, R, Ramagopalan, S, Kawano, Y, Nishimura, Y, Ebers, G, Kira, J

The ITPA disruption database by Eidietis, N.W., Gerhardt, S.P., Kawano, Y., Lehnen, M., Lister, J.B., Pautasso, G., Riccardo, V., Tanna, R.L., Thornton, A.J., ITPA Disruption Database Participants, Granetz, Robert S

Get full text

Lysine demethylase 5A is required for MYC-driven transcription in multiple myeloma by Ohguchi, H, Park, PMC, Wang, T, Gryder, BE, Ogiya, D, Kurata, K, Zhang, X, Li, D, Pei, C, Masuda, T, Johansson, C, Wimalasena, VK, Kim, Y, Hino, S, Usuki, S, Kawano, Y, Samur, MK, Tai, Y-T, Munshi, NC, Matsuoka, M, Ohtsuki, S, Nakao, M, Minami, T, Lauberth, S, Khan, J, Oppermann, U, Durbin, AD, Anderson, KC, Hideshima, T, Qi, J